Sales & Marketing Sponsored 12 Questions with Kirsten Parr Kirsten Parr heads up CMC Connect, a division of IPG Health Medical Communications, and has over 25 years’ experience in the industry.
News FDA clears AZ's Imfinzi for aggressive lung cancer AstraZeneca's Imfinzi becomes the first cancer immunotherapy to be FDA-approved for limited-stage small cell lung cancer (LS-SCLC).
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.